Yohei Takenaka
Overview
Explore the profile of Yohei Takenaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
4
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takenaka Y, Tanaka T, Otaki S, Kanbe A, Morita T, Yokoi K, et al.
Biol Pharm Bull
. 2024 Dec;
47(12):2101-2118.
PMID: 39710379
Excessive inflammatory responses to viral infections, known as cytokine storms, are caused by overactivation of endolysosomal Toll-like receptors (TLRs) (TLR3, TLR7, TLR8, and TLR9) and can be lethal, but no...
2.
Takenaka Y, Tanaka R, Kitabatake K, Uchiumi F, Aoki S, Kuramochi K, et al.
Biol Pharm Bull
. 2024 May;
47(5):946-954.
PMID: 38735732
There is accumulating evidence that selective serotonin reuptake inhibitors (SSRIs), clinically used as antidepressants, have a beneficial effect on inflammatory diseases such as coronavirus disease 2019 (COVID-19). We previously compared...
3.
Takenaka Y, Tanaka R, Kitabatake K, Kuramochi K, Aoki S, Tsukimoto M
Front Pharmacol
. 2022 Jul;
13:874375.
PMID: 35814203
Excessive proinflammatory cytokine production induced by abnormal activation of Toll-like receptor (TLR) signaling, for example, by SARS-CoV-2 infection, can cause a fatal cytokine storm. The selective serotonin reuptake inhibitors (SSRIs)...